UBE (OTCMKTS:UBEOY) vs. Moolec Science (NASDAQ:MLEC) Critical Comparison

UBE (OTCMKTS:UBEOY) and Moolec Science (NASDAQ:MLEC) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, profitability, valuation, earnings and risk.

Insider & Institutional Ownership

0.1% of Moolec Science shares are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Volatility and Risk

UBE has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Moolec Science has a beta of -0.49, meaning that its stock price is 149% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for UBE and Moolec Science, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
UBE	0	0	0	0	N/A
Moolec Science	0	0	3	0	3.00

Moolec Science has a consensus price target of $5.50, suggesting a potential upside of 358.33%. Given Moolec Science’s higher probable upside, analysts clearly believe Moolec Science is more favorable than UBE.

Profitability

This table compares UBE and Moolec Science’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
UBE	3.73%	7.60%	3.66%
Moolec Science	N/A	-69.56%	-29.51%

Valuation & Earnings

This table compares UBE and Moolec Science’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UBE	$5.84 billion	0.28	$218.05 million	$1.10	7.11
Moolec Science	$900,000.00	50.08	-$51.79 million	N/A	N/A

UBE has higher revenue and earnings than Moolec Science.

Summary

UBE beats Moolec Science on 6 of the 11 factors compared between the two stocks.

About UBE

Ube Industries, Ltd., together with its subsidiaries, engages in the chemicals, construction materials, and machinery businesses in Japan, Asia, Europe, and internationally. The company operates through four segments: Chemicals, Construction Materials, Machinery, and Others. It offers synthetic rubber, engineering plastics, caprolactam, industrial chemicals, liquefied gas, polyethylene, ammonium sulfate, polyimide, battery materials, separation membranes, fine chemicals, ceramics, high purity chemicals, semiconductor gas products, products for polyurethane resins, aerospace materials, inorganic fiber, and high temperature paints. The company also provides contract manufacturing services for APIs and intermediates; aromatic SF5 compounds; FLUOLEAD, a novel nucleophilic fluorinating agent; and drug discovery and pipeline services. In addition, it offers cement products, ready mixed concrete, soil stabilizing cement, building materials, limestone, calcia and magnesia, specialty inorganic materials, and resource recycling, as well as imports and sells coal. Further, the company is involved in the supply of electric power. Additionally, it provides die-casting and injection molding machines, and extrusion presses; and UBE vertical mills, kilins, furnaces, dryers, water screening equipment, storage and transportation systems, bridges and steel structures, and steel billets and casting. The company also manufactures and sells nylon, plastic films, polypropylene molded products, fibers, fiber-reinforced plastics, electronic and information materials, magnesia clinker, quicklime, slaked lime, and cast iron; and offers coastal shipping, port transportation, containers, collection and transport of industrial waste, trading, and engineering services. In addition, it engages in the purchase, sale, and leasing of real estate properties. Ube Industries, Ltd. was founded in 1897 and is headquartered in Tokyo, Japan.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.